Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T00:44:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T17:38:14.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T13:22:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has been updated to reflect that it is currently active and not recruiting, with several important dates added for future events. Additionally, all previous contact information for the study's principal and sub-investigators has been removed.
    Difference
    6%
    Check dated 2025-05-15T03:04:28.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T20:33:10.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed descriptions of the study's methodology and eligibility criteria for patients with advanced pancreas adenocarcinoma, while retaining key information about the study's design and collaborators.
    Difference
    37%
    Check dated 2025-04-16T14:21:14.000Z thumbnail image

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.